Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Predicting Patient Status in Chronic Thromboembolic Pulmonary Hypertension Using a Biophysical Model.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2023
Same author

Blunt bronchial injury management with veno-venous extracorporeal membrane oxygenation providing a peri-operative 'survival bridge'.

Trauma case reports·2020
Same author

Detection of haplotype-dependent allele-specific DNA methylation in WGBS data.

Nature communications·2020
Same author

Autoantibodies to killer cell immunoglobulin-like receptor 3DL1 in patients with systemic lupus erythematosus.

Clinical and experimental immunology·2018
Same author

Clinical and clinicopathological characteristics of acute lymphoblastic leukaemia in six cats.

The Journal of small animal practice·2018
Same author

Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018

Video Experimental Relacionado

Updated: Jun 10, 2026

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
12:08

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells

Published on: March 10, 2016

Memoria epigenética en las células madre pluripotentes inducidas.

K Kim1, A Doi, B Wen

  • 1Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Children's Hospital Boston and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA

Nature
|July 21, 2010
PubMed
Resumen

La transferencia nuclear de células somáticas (SCNT) es más efectiva que la reprogramación basada en el factor de transcripción para lograr la pluripotencia. Las células derivadas de SCNT muestran menos recuerdos epigenéticos, lo que permite un potencial de diferenciación más amplio en comparación con las células madre pluripotentes inducidas (iPSC).

Más Videos Relacionados

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

Generation and Maintenance of Primate Induced Pluripotent Stem Cells Derived from Urine
07:46

Generation and Maintenance of Primate Induced Pluripotent Stem Cells Derived from Urine

Published on: July 28, 2023

Videos de Experimentos Relacionados

Last Updated: Jun 10, 2026

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
12:08

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells

Published on: March 10, 2016

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

Generation and Maintenance of Primate Induced Pluripotent Stem Cells Derived from Urine
07:46

Generation and Maintenance of Primate Induced Pluripotent Stem Cells Derived from Urine

Published on: July 28, 2023

Área de la Ciencia:

  • La epigenética es la epigenética.
  • Biología de las células madre Biología de las células madre
  • Biología del desarrollo Biología del desarrollo.

Sus antecedentes:

  • La transferencia nuclear de células somáticas (SCNT) y la reprogramación basada en el factor de transcripción son métodos para generar células madre pluripotentes a partir de células adultas.
  • Ambos métodos restablecen la metilación genómica, una modificación epigenética que influye en la expresión génica.
  • Las diferencias en los mecanismos de reprogramación sugieren posibles variaciones en las propiedades de las células madre pluripotentes resultantes.

Objetivo del estudio:

  • Investigar las diferencias en los estados epigenéticos y el potencial de diferenciación entre las células madre pluripotentes inducidas (iPSC) y las derivadas de SCNT.
  • Determinar si la memoria epigenética del tejido somático de origen influye en las propiedades de las iPSCs.
  • Para comparar la efectividad de la SCNT y la reprogramación basada en factores en el establecimiento del estado fundamental de la pluripotencia.

Principales métodos:

  • Comparación de los patrones de metilación del ADN en iPSC de paso bajo y células madre pluripotentes derivadas de SCNT.
  • Evaluación del potencial de diferenciación a lo largo de varios linajes celulares.
  • Tratamiento de las iPSC con fármacos modificadores de la cromatina para investigar el restablecimiento epigenético de la memoria.

Principales resultados:

  • Los iPSC retienen las firmas de metilación del ADN residual de su tejido somático de origen, favoreciendo la diferenciación específica del donante.
  • Esta "memoria epigenética" en las iPSCs restringe los destinos celulares alternativos, pero se puede restablecer.
  • Las células madre pluripotentes derivadas de SCNT exhiben patrones de diferenciación y metilación más parecidos a las células madre embrionarias que las iPSC.

Conclusiones:

  • SCNT es más eficaz que la reprogramación basada en factores para establecer el estado fundamental de la pluripotencia.
  • La reprogramación basada en factores puede dejar una memoria epigenética que influye en la diferenciación dirigida.
  • Comprender estas diferencias epigenéticas es crucial para las aplicaciones en el modelado de enfermedades y la medicina regenerativa.